Roivant Sciences (ROIV) Cash from Investing Activities (2020 - 2025)
Roivant Sciences' Cash from Investing Activities history spans 6 years, with the latest figure at $109.5 million for Q4 2025.
- For Q4 2025, Cash from Investing Activities rose 103.85% year-over-year to $109.5 million; the TTM value through Dec 2025 reached -$3.7 billion, down 293.92%, while the annual FY2025 figure was -$1.8 billion, 133.94% down from the prior year.
- Cash from Investing Activities reached $109.5 million in Q4 2025 per ROIV's latest filing, down from $120.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $5.2 billion in Q4 2023 to a low of -$3.3 billion in Q3 2024.
- Average Cash from Investing Activities over 5 years is -$101.2 million, with a median of -$2.3 million recorded in 2021.
- Peak YoY movement for Cash from Investing Activities: skyrocketed 3392.76% in 2023, then plummeted 112409.43% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at $309.0 million in 2021, then tumbled by 151.08% to -$157.8 million in 2022, then surged by 3392.76% to $5.2 billion in 2023, then plummeted by 154.66% to -$2.8 billion in 2024, then surged by 103.85% to $109.5 million in 2025.
- Per Business Quant, the three most recent readings for ROIV's Cash from Investing Activities are $109.5 million (Q4 2025), $120.4 million (Q3 2025), and -$1.1 billion (Q2 2025).